These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38859656)

  • 1. Pharmacogenetics of Efavirenz Exposure in Cervicovaginal Fluid during Pregnancy and Postpartum.
    Eniayewu O; Azuka U; Ogah J; Adejuyigbe E; Bolaji O; Olagunju A
    Clin Pharmacol Ther; 2024 Jun; ():. PubMed ID: 38859656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of pregnancy-induced changes in efavirenz pharmacokinetics.
    Olagunju A; Bolaji O; Amara A; Else L; Okafor O; Adejuyigbe E; Oyigboja J; Back D; Khoo S; Owen A
    Clin Pharmacol Ther; 2015 Mar; 97(3):298-306. PubMed ID: 25669165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants.
    Holzinger ER; Grady B; Ritchie MD; Ribaudo HJ; Acosta EP; Morse GD; Gulick RM; Robbins GK; Clifford DB; Daar ES; McLaren P; Haas DW
    Pharmacogenet Genomics; 2012 Dec; 22(12):858-67. PubMed ID: 23080225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa.
    Sinxadi PZ; Leger PD; McIlleron HM; Smith PJ; Dave JA; Levitt NS; Maartens G; Haas DW
    Br J Clin Pharmacol; 2015 Jul; 80(1):146-56. PubMed ID: 25611810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast milk pharmacokinetics of efavirenz and breastfed infants' exposure in genetically defined subgroups of mother-infant pairs: an observational study.
    Olagunju A; Bolaji O; Amara A; Waitt C; Else L; Adejuyigbe E; Siccardi M; Back D; Khoo S; Owen A
    Clin Infect Dis; 2015 Aug; 61(3):453-63. PubMed ID: 25882300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy affects nevirapine pharmacokinetics: evidence from a CYP2B6 genotype-guided observational study.
    Olagunju A; Bolaji O; Neary M; Back D; Khoo S; Owen A
    Pharmacogenet Genomics; 2016 Aug; 26(8):381-9. PubMed ID: 27195527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2B6 516G>T (rs3745274) and smoking status are associated with efavirenz plasma concentration in a Serbian cohort of HIV patients.
    Olagunju A; Siccardi M; Amara A; Jevtovic D; Kusic J; Owen A; Dragovic G
    Ther Drug Monit; 2014 Dec; 36(6):734-8. PubMed ID: 24831655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rilpivirine Plasma and Cervicovaginal Concentrations in Women During Pregnancy and Postpartum.
    Eke AC; Chakhtoura N; Kashuba A; Best BM; Sykes C; Wang J; Stek AM; Smith E; Calabrese S; Capparelli EV; Mirochnick M;
    J Acquir Immune Defic Syndr; 2018 Jul; 78(3):308-313. PubMed ID: 29528944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal efavirenz exposure is independently associated with maternal, but not fetal CYP2B6 genotype.
    Eniayewu O; Akinloye A; Shenkoya B; Azuka U; Bolaji O; Adejuyigbe E; Owen A; Olagunju A
    Pharmacogenet Genomics; 2024 Oct; 34(8):253-260. PubMed ID: 38934229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine.
    Neary M; Lamorde M; Olagunju A; Darin KM; Merry C; Byakika-Kibwika P; Back DJ; Siccardi M; Owen A; Scarsi KK
    Clin Pharmacol Ther; 2017 Sep; 102(3):529-536. PubMed ID: 28187506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic predictors of variability in efavirenz pharmacokinetics in an admixed Brazilian HIV cohort.
    Ximenez JP; Elias ABR; Nardotto GHB; Barroso PF; Bollela VR; Lanchote VL; Suarez-Kurtz G
    Br J Clin Pharmacol; 2022 Oct; 88(10):4585-4594. PubMed ID: 35514050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of selected polymorphisms in disposition genes on lumefantrine pharmacokinetics when coadministered with efavirenz.
    Adegbola AJ; Rana A; Adeagbo BA; Bolarinwa RA; Olagunju AE; Siccardi M; Owen A; Bolaji OO
    Pharmacogenet Genomics; 2020 Jul; 30(5):96-106. PubMed ID: 32209837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study.
    Ribaudo HJ; Haas DW; Tierney C; Kim RB; Wilkinson GR; Gulick RM; Clifford DB; Marzolini C; Fletcher CV; Tashima KT; Kuritzkes DR; Acosta EP;
    Clin Infect Dis; 2006 Feb; 42(3):401-7. PubMed ID: 16392089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of efavirenz and treatment of HIV-1 among pregnant women with and without tuberculosis coinfection.
    Dooley KE; Denti P; Martinson N; Cohn S; Mashabela F; Hoffmann J; Haas DW; Hull J; Msandiwa R; Castel S; Wiesner L; Chaisson RE; McIlleron H;
    J Infect Dis; 2015 Jan; 211(2):197-205. PubMed ID: 25081933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosage Optimization of Efavirenz Based on a Population Pharmacokinetic-Pharmacogenetic Model of HIV-infected Patients in Thailand.
    Chaivichacharn P; Avihingsanon A; Manosuthi W; Ubolyam S; Tongkobpetch S; Shotelersuk V; Punyawudho B
    Clin Ther; 2020 Jul; 42(7):1234-1245. PubMed ID: 32451120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of the Late-Onset Efavirenz Neurotoxicity Syndrome (LENS).
    van Rensburg R; Nightingale S; Brey N; Albertyn CH; Kellermann TA; Taljaard JJ; Esterhuizen TM; Sinxadi PZ; Decloedt EH
    Clin Infect Dis; 2022 Aug; 75(3):399-405. PubMed ID: 34882770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of HIV infection and menopause status on raltegravir pharmacokinetics in the blood and genital tract.
    Cottrell ML; Patterson KB; Prince HM; Jones A; White N; Wang R; Kashuba AD
    Antivir Ther; 2015; 20(8):795-803. PubMed ID: 26040011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetic associations with plasma efavirenz concentrations and clinical correlates in a retrospective cohort of Ghanaian HIV-infected patients.
    Sarfo FS; Zhang Y; Egan D; Tetteh LA; Phillips R; Bedu-Addo G; Sarfo MA; Khoo S; Owen A; Chadwick DR
    J Antimicrob Chemother; 2014 Feb; 69(2):491-9. PubMed ID: 24080498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Pregnancy on the Pharmacokinetic Interaction between Efavirenz and Lumefantrine in HIV-Malaria Coinfection.
    Adegbola A; Abutaima R; Olagunju A; Ijarotimi O; Siccardi M; Owen A; Soyinka J; Bolaji O
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30082286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma efavirenz concentrations and the association with CYP2B6-516G >T polymorphism in HIV-infected Thai children.
    Puthanakit T; Tanpaiboon P; Aurpibul L; Cressey TR; Sirisanthana V
    Antivir Ther; 2009; 14(3):315-20. PubMed ID: 19474465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.